Among these, the BRCA2 Met1915Thr (rs4987117) variant has drawn particular attention due to its location within the RAD51-binding BRC repeat domain—critical for DNA repair function—and its potential role in modulating cancer risk. The gene discussed is RAD51; the disease is cancer.